Ruedi E Waeger - Net Worth and Insider Trading

Ruedi E Waeger Net Worth

The estimated net worth of Ruedi E Waeger is at least $9 Million dollars as of 2024-04-23. Ruedi E Waeger is the Director of Alexion Pharmaceuticals Inc and owns about 48,108 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $9 Million. Details can be seen in Ruedi E Waeger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ruedi E Waeger has not made any transactions after 2010-05-03 and currently still holds the listed stock(s).

Transaction Summary of Ruedi E Waeger

To

Ruedi E Waeger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ruedi E Waeger owns 1 companies in total, including Alexion Pharmaceuticals Inc (ALXN) .

Click here to see the complete history of Ruedi E Waeger’s form 4 insider trades.

Insider Ownership Summary of Ruedi E Waeger

Ticker Comapny Transaction Date Type of Owner
ALXN Alexion Pharmaceuticals Inc 2010-05-03 director

Ruedi E Waeger Latest Holdings Summary

Ruedi E Waeger currently owns a total of 1 stock. Ruedi E Waeger owns 48,108 shares of Alexion Pharmaceuticals Inc (ALXN) as of May 3, 2010, with a value of $9 Million.

Latest Holdings of Ruedi E Waeger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2010-05-03 48,108 182.50 8,779,710

Holding Weightings of Ruedi E Waeger


Ruedi E Waeger Form 4 Trading Tracker

According to the SEC Form 4 filings, Ruedi E Waeger has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the acquisition of 6,000 shares on May 3, 2010, which cost Ruedi E Waeger around $165,300.

Insider Trading History of Ruedi E Waeger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ruedi E Waeger Trading Performance

GuruFocus tracks the stock performance after each of Ruedi E Waeger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ruedi E Waeger is 2.95%. GuruFocus also compares Ruedi E Waeger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ruedi E Waeger within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ruedi E Waeger's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ruedi E Waeger

Average Return

76.27%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.91 2.95 28.24 76.27 81.82 52.81
Relative Return to S&P 500(%) 5.36 9.75 28.6 63.43 74.25 42.5

Ruedi E Waeger Ownership Network

Ownership Network List of Ruedi E Waeger

No Data

Ownership Network Relation of Ruedi E Waeger


Ruedi E Waeger Owned Company Details

What does Alexion Pharmaceuticals Inc do?

Who are the key executives at Alexion Pharmaceuticals Inc?

Ruedi E Waeger is the director of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .

Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alexion Pharmaceuticals Inc Insider Transactions

No Available Data

Ruedi E Waeger Mailing Address

Above is the net worth, insider trading, and ownership report for Ruedi E Waeger. You might contact Ruedi E Waeger via mailing address: C/o Alexion Pharmaceuticals, Inc. 352 Knotter Drive Cheshire Ct 06410.

Discussions on Ruedi E Waeger

No discussions yet.